{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:56:27Z","timestamp":1791845787909,"version":"4.3.4"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2014,4,2]],"date-time":"2014-04-02T00:00:00Z","timestamp":1396396800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0088680","type":"journal-article","created":{"date-parts":[[2014,4,2]],"date-time":"2014-04-02T23:01:53Z","timestamp":1396479713000},"page":"e88680","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":85,"title":["Cerebrospinal Fluid Immunoglobulin Kappa Light Chain in Clinically Isolated Syndrome and Multiple Sclerosis"],"prefix":"10.1371","volume":"9","author":[{"given":"Makbule","family":"Senel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayrettin","family":"Tumani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Lauda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Presslauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehaneh","family":"Mojib-Yezdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Brettschneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,4,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(11)70274-5","article-title":"Clinically isolated syndromes","volume":"11","author":"DH Miller","year":"2012","journal-title":"Lancet Neurol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1007\/s00415-010-5601-9","article-title":"The radiologically isolated syndrome: Take action when the unexpected is uncovered?","volume":"257","author":"J Sellner","year":"2010","journal-title":"J Neurol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1177\/1352458509107007","article-title":"Treatment of early multiple sclerosis: The value of treatment initiation after a first clinical episode","volume":"15","author":"DS Goodin","year":"2009","journal-title":"Mult Scler"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jneuroim.2010.05.032","article-title":"The risk of relapse after a clinically isolated syndrome is related to the pattern of oligoclonal bands","volume":"226","author":"I Bosca","year":"2010","journal-title":"J Neuroimmunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e11986","DOI":"10.1371\/journal.pone.0011986","article-title":"The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS)","volume":"5","author":"J Brettschneider","year":"2010","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/brain\/awq035","article-title":"Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis","volume":"133","author":"M Comabella","year":"2010","journal-title":"Brain"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/1352458510385506","article-title":"Prognostic value of cerebrospinal fluid analysis at the time of a first demyelinating event","volume":"17","author":"O Gout","year":"2011","journal-title":"Mult Scler"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1212\/01.wnl.0000277704.56189.85","article-title":"Clinically isolated syndromes: Predicting and delaying multiple sclerosis","volume":"68","author":"BW Thrower","year":"2007","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1212\/01.wnl.0000280576.73609.c6","article-title":"Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?","volume":"70","author":"M Tintore","year":"2008","journal-title":"Neurology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1155\/2006\/509476","article-title":"Multiple sclerosis cerebrospinal fluid biomarkers","volume":"22","author":"G Giovannoni","year":"2006","journal-title":"Dis Markers"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.nbd.2009.04.010","article-title":"Cerebrospinal fluid biomarkers in multiple sclerosis","volume":"35","author":"H Tumani","year":"2009","journal-title":"Neurobiol Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrneurol.2013.41","article-title":"The utility of cerebrospinal fluid analysis in patients with multiple sclerosis","volume":"9","author":"M Stangel","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1373\/clinchem.2007.089052","article-title":"Interlaboratory reproducibility of isoelectric focusing in oligoclonal band detection","volume":"53","author":"D Franciotta","year":"2007","journal-title":"Clin Chem"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jneuroim.2010.09.002","article-title":"Free light chain monomers in the diagnosis of multiple sclerosis","volume":"229","author":"B Kaplan","year":"2010","journal-title":"J Neuroimmunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0165-5728(88)90041-0","article-title":"Free kappa and lambda light chain levels in the cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases","volume":"19","author":"OC Fagnart","year":"1988","journal-title":"J Neuroimmunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1212\/WNL.39.7.964","article-title":"Relative diagnostic value of cerebrospinal fluid kappa chains in MS: Comparison with other immunoglobulin tests","volume":"39","author":"RA Rudick","year":"1989","journal-title":"Neurology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-0404.1998.tb07287.x","article-title":"Intrathecal synthesis of free immunoglobulin light chains in multiple sclerosis","volume":"98","author":"M Krakauer","year":"1998","journal-title":"Acta Neurol Scand"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1373\/clinchem.2004.033977","article-title":"Kappa free light chains in cerebrospinal fluid as markers of intrathecal immunoglobulin synthesis","volume":"50","author":"C Fischer","year":"2004","journal-title":"Clin Chem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s10875-005-5371-9","article-title":"Quantification of immunoglobulin free light chains in cerebrospinal fluid by nephelometry","volume":"25","author":"S Desplat-Jego","year":"2005","journal-title":"J Clin Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1007\/s00415-008-0954-z","article-title":"Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis","volume":"255","author":"S Presslauer","year":"2008","journal-title":"J Neurol"},{"issue":"(Pt 11)","key":"ref21","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/brain\/120.11.2059","article-title":"Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis","volume":"120","author":"F Barkhof","year":"1997","journal-title":"Brain"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jns.2010.08.009","article-title":"Humoral autoimmunity in multiple sclerosis","volume":"306","author":"E Meinl","year":"2011","journal-title":"J Neurol Sci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e7638","DOI":"10.1371\/journal.pone.0007638","article-title":"IgG antibodies against measles, rubella, and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndrome","volume":"4","author":"J Brettschneider","year":"2009","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e11986","DOI":"10.1371\/journal.pone.0011986","article-title":"The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS)","volume":"5","author":"J Brettschneider","year":"2010","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2013.06.014","article-title":"Intrathecal oligoclonal IgG synthesis in multiple sclerosis","volume":"262","author":"A Petzold","year":"2013","journal-title":"J Neuroimmunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"CH Polman","year":"2011","journal-title":"Ann Neurol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)","volume":"33","author":"JF Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","article-title":"A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking","volume":"73","author":"CE Teunissen","year":"2009","journal-title":"Neurology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s004150050214","article-title":"Neuroborreliosis","volume":"245","author":"R Kaiser","year":"1998","journal-title":"J Neurol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/jnnp.2009.195438","article-title":"The chemokine CXCL13 in acute neuroborreliosis","volume":"81","author":"M Senel","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1515\/CCLM.2001.051","article-title":"Reporting cerebrospinal fluid data: Knowledge base and interpretation software","volume":"39","author":"H Reiber","year":"2001","journal-title":"Clin Chem Lab Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-510X(00)00501-3","article-title":"Cerebrospinal fluid analysis: Disease-related data patterns and evaluation programs","volume":"184","author":"H Reiber","year":"2001","journal-title":"J Neurol Sci"},{"issue":"(Pt 5)","key":"ref33","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1177\/000456329002700504","article-title":"Isoelectric focusing of cerebrospinal fluid immunoglobulin G: An annotated update","volume":"27","author":"G Keir","year":"1990","journal-title":"Ann Clin Biochem"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/bmj.304.6823.381-c","article-title":"Confidence intervals: Enlightening or mystifying?","volume":"304","author":"RG Newcombe","year":"1992","journal-title":"BMJ"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/ana.20890","article-title":"B lineage cells in the inflammatory central nervous system environment: Migration, maintenance, local antibody production, and therapeutic modulation","volume":"59","author":"E Meinl","year":"2006","journal-title":"Ann Neurol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1100\/tsw.2011.65","article-title":"Immunoglobulin free light chain dimers in human diseases","volume":"11","author":"B Kaplan","year":"2011","journal-title":"ScientificWorldJournal"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ejphar.2005.12.065","article-title":"Free immunoglobulin light chains as target in the treatment of chronic inflammatory diseases","volume":"533","author":"M van der Heijden","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0008-8749(86)90191-7","article-title":"Evidence by radioimmunoassay that mitogen-activated human blood mononuclear cells secrete significant amounts of light chain ig unassociated with heavy chain","volume":"101","author":"JE Hopper","year":"1986","journal-title":"Cell Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/clinchem\/48.10.1805","article-title":"Trimolecular complexes of lambda light chain dimers in serum of a patient with multiple myeloma","volume":"48","author":"RS Abraham","year":"2002","journal-title":"Clin Chem"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1365-2249.1998.00487.x","article-title":"Differences in kappa to lambda (kappa:Lambda) ratios of serum and urinary free light chains","volume":"111","author":"M Abe","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/clinchem\/47.4.673","article-title":"Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine","volume":"47","author":"AR Bradwell","year":"2001","journal-title":"Clin Chem"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1600-0404.2008.01058.x","article-title":"High sensitivity of free lambda and free kappa light chains for detection of intrathecal immunoglobulin synthesis in cerebrospinal fluid","volume":"119","author":"B Arneth","year":"2009","journal-title":"Acta Neurol Scand"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0165-5728(95)00086-H","article-title":"Cerebrospinal fluid free kappa light chains versus IgG findings in neurological disorders: Qualitative and quantitative measurements","volume":"62","author":"KJ Lamers","year":"1995","journal-title":"J Neuroimmunol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1212\/WNL.37.8.1334","article-title":"Free light chains in multiple sclerosis and infections of the CNS","volume":"37","author":"C DeCarli","year":"1987","journal-title":"Neurology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0022-510X(76)90259-8","article-title":"Evaluation of the blood-CSF barrier by protein gradients and the humoral immune response within the central nervous system","volume":"30","author":"K Felgenhauer","year":"1976","journal-title":"J Neurol Sci"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.clineuro.2011.12.051","article-title":"Comparison of two methods for the detection of oligoclonal bands in a large number of clinically isolated syndrome and multiple sclerosis patients","volume":"114","author":"A Andlovic","year":"2012","journal-title":"Clin Neurol Neurosurg"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jneuroim.2006.07.006","article-title":"Oligoclonal bands in multiple sclerosis cerebrospinal fluid: An update on methodology and clinical usefulness","volume":"180","author":"H Link","year":"2006","journal-title":"J Neuroimmunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/jnnp.57.8.897","article-title":"Cerebrospinal fluid in the diagnosis of multiple sclerosis: A consensus report","volume":"57","author":"M Andersson","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"520; author reply 521","DOI":"10.1002\/ana.22508","article-title":"Revised McDonald criteria: The persisting importance of cerebrospinal fluid analysis","volume":"70","author":"H Tumani","year":"2011","journal-title":"Ann Neurol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0088680","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T04:49:42Z","timestamp":1597639782000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0088680"}},"subtitle":[],"editor":[{"given":"Markus","family":"Reindl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,4,2]]},"references-count":49,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,4,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0088680","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,2]]}}}